Granulocyte-macrophage colony-stimulating factor in the management of severe ecthyma gangrenosum related to myelodysplastic syndrome.
Bécherel
P A
PA
Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Chosidow
O
O
Berger
E
E
Martin
S
S
Khayat
D
D
Herson
S
S
Francès
C
C
D000368:Aged; D000900:Anti-Bacterial Agents; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004473:Ecthyma / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D005734:Gangrene; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000188:drug therapy*; D009503:Neutropenia / Q000150:complications; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor